πŸ“˜ **Comprehensive Guide on Zolpidem Tartrate API Manufactured by Swapnroop Drugs & Pharmaceuticals** πŸ’ŠπŸŒ™✨

 


Q1 — What is Zolpidem Tartrate API (manufactured by Swapnroop Drugs & Pharmaceuticals)? — πŸ’€πŸ”¬✨

Short definition (one line):
Zolpidem tartrate API is the active pharmaceutical ingredient used to make zolpidem-containing hypnotic (sleep) medications — a non-benzodiazepine GABA_A receptor modulator prescribed for short-term treatment of insomnia. πŸŒ™πŸ’Š


Chemical & identity snapshot 🧩

  • Common name: Zolpidem tartrate (API is the zolpidem base often supplied as the tartrate salt).

  • IUPAC name (zolpidem): N,N,6-trimethyl-2-p-tolylimidazo[1,2-a]pyridine-3-acetamide (tartrate is the salt form).

  • Molecular formula (zolpidem base): C19H21N3O

  • CAS number (zolpidem tartrate): 82626-48-0 (tartrate salt identifiers are commonly used in regulatory docs). πŸ”Ž

  • Appearance: White to off-white crystalline powder (tartrate salt), free-flowing when properly dried. ❄️

If you need exact molar mass or alternate identifiers for regulatory filings, I can add them.


Pharmacology — mechanism of action ⚙️🧠

  • Mechanism: Zolpidem is a positive allosteric modulator of GABA_A receptors, with preferential binding to the Ξ±1 subunit. This potentiates GABAergic inhibition in the CNS and produces hypnotic (sleep-inducing) effects.

  • Classification: Non-benzodiazepine “Z-drug” hypnotic (different chemical class but acts on the benzodiazepine binding site of GABA_A). 🧬


Therapeutic use (clinical role) πŸ©ΊπŸŒ™

  • Primary indication: Short-term management of insomnia — particularly for difficulty initiating sleep.

  • Typical clinical goal: Reduce sleep latency (time to fall asleep), and in some formulations help maintain sleep for a limited duration. ⏱️

  • Use constraints: Usually recommended for short durations (a few weeks) due to tolerance, dependence, and next-day impairment risks.


Key pharmaceutical attributes and why the API matters ✅

  • Salt form (tartrate) improves aqueous solubility and stability versus the free base, aiding formulation into tablets and oral dispersible forms.

  • Particle size & crystal form influence dissolution rate, content uniformity, and bioavailability — critical for a molecule with rapid onset expectations.

  • High purity & controlled residual solvents ensure patient safety and predictable pharmacokinetics. πŸ§ͺ


Safety profile & precautions ⚠️

  • Common adverse effects: Drowsiness, dizziness, headache, somnolence, nausea, and coordination impairment. 😴

  • Serious/important risks: Complex sleep-related behaviors (sleepwalking, sleep-driving), next-day impairment, risk of dependence and withdrawal with prolonged use, and potential for respiratory depression especially when combined with CNS depressants (alcohol, opioids). 🚨

  • Contraindications/Cautions: Severe hepatic impairment (dose adjustment or avoidance), history of complex sleep behaviors, concomitant use with strong CYP3A4 inhibitors/inducers may alter exposure. Use with caution in elderly (increased sensitivity; fall risk). 🩹


Formulation & dosing relevance πŸ’Š

  • Typical strengths: 5 mg and 10 mg immediate-release tablets (strengths vary by market and patient population).

  • Onset expectation: Rapid absorption → fast onset of action; formulations are designed to dissolve and release zolpidem quickly for sleep initiation. ⚡

  • Implication for API: Fast dissolution performance required — particle engineering (micronization) and appropriate salt/crystal form control are important.


Quality & regulatory expectations 🏷️πŸ“‹

Customers expect zolpidem tartrate API to be supplied with:

  • Certificate of Analysis (CoA) showing assay, impurities, residual solvent results, moisture content, and microbial limits.

  • GMP compliance, batch traceability, and stability data suitable for dossier submission in regulated markets. πŸ›️


Packaging & storage (API commercial view) πŸ“¦πŸŒ‘️

  • Packaging: Double-lined polyethylene bags inside HDPE or fiber drums (desiccant and light-resistant inner liner if moisture/light sensitive).

  • Storage: Cool, dry place; typically below 25°C and protected from moisture/light to maintain potency and prevent degradation. 🧊


Why Swapnroop’s supply matters to buyers 🀝

Buyers look for: robust impurity control, reproducible particle size, validated analytical methods, and documentation for regulatory filings. A consistent, pharmacopeial-grade zolpidem tartrate API from Swapnroop enables reliable finished products (tablets/ODTs) that perform predictably in patients. πŸ“¦✅


2️⃣ What is Zolpidem Tartrate API by Swapnroop Drugs & Pharmaceuticals used for?

πŸ’€ Primary Use:
Zolpidem Tartrate API is used in the manufacturing of hypnotic medications designed to treat insomnia, especially for patients who have difficulty falling asleep or maintaining sleep. πŸ›️

🧠 Pharmacological Role:
It acts on the GABA-A receptor complex, enhancing the activity of GABA (the brain’s main inhibitory neurotransmitter). This results in CNS depression, leading to sedation, relaxation, and sleep induction.

πŸ’Š Therapeutic Applications:

  • Treatment of short-term insomnia πŸ’€

  • Managing sleep onset difficulties ⏱️

  • As part of pre-anesthetic medication in some clinical settings πŸ’‰

⚠️ Note: Long-term use is discouraged due to potential for tolerance and dependence.


3️⃣ What are the physicochemical properties of Zolpidem Tartrate API manufactured by Swapnroop Drugs & Pharmaceuticals?

πŸ§ͺ Physicochemical Profile:

  • Chemical Name: N,N,6-Trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide tartrate

  • Molecular Formula: C19H21N3O·C4H6O6

  • Molecular Weight: ~764.9 g/mol (tartrate salt) ⚖️

  • Appearance: White to off-white crystalline powder ❄️

  • Odor: Odorless

  • Taste: Slightly bitter

  • Solubility:

    • Freely soluble in water and methanol πŸ’§

    • Sparingly soluble in ethanol 🍢

    • Practically insoluble in non-polar solvents (e.g., hexane)

  • Melting Point: ~193–196°C 🌑️

  • pKa: 6.2 (weakly basic)

  • Log P: ~2.2 (moderate lipophilicity)

  • Hygroscopicity: Slightly hygroscopic; requires dry storage 🧴

πŸ”¬ These properties make it ideal for oral solid dosage forms, as the tartrate salt ensures good solubility and bioavailability.


4️⃣ How is Zolpidem Tartrate API manufactured (synthesized) by Swapnroop Drugs & Pharmaceuticals?

⚗️ Synthesis Overview:
Zolpidem Tartrate is synthesized through a multi-step organic synthesis involving condensation, cyclization, and amidation reactions. Below is a general outline (simplified):

  1. Formation of Imidazopyridine Core

    • The reaction between 2-amino-5-methylpyridine and benzoylacetate derivatives forms the imidazo[1,2-a]pyridine ring system πŸ”„

  2. N-Methylation

    • The imidazopyridine intermediate undergoes methylation at the nitrogen atom using a suitable methylating agent like dimethyl sulfate or methyl iodide πŸ§ͺ

  3. Acetamide Formation

    • Introduction of the acetamide side chain via acetylation or amidation reactions creates the active moiety responsible for hypnotic activity 🧬

  4. Salt Formation (Tartrate)

    • The free base is converted into Zolpidem Tartrate by reaction with tartaric acid in a suitable solvent (e.g., ethanol or isopropanol). This enhances solubility and stability πŸ’§

  5. Purification and Crystallization

    • The final API is purified by recrystallization and dried under controlled conditions to achieve pharmacopeial purity standards. 🌑️

🏭 Swapnroop’s Process Advantage:

  • Uses GMP-compliant synthesis

  • Validated analytical controls at each step

  • Focus on low residual solvent and controlled polymorphism for high-quality, stable API ✅


5️⃣ What are the different dosage forms of Zolpidem Tartrate manufactured using the API?

πŸ’Š Common Dosage Forms:

  1. Immediate-Release Tablets (5 mg, 10 mg) — for quick sleep induction πŸ•“

  2. Extended-Release Tablets (ER) — for patients with difficulty maintaining sleep πŸŒ™

  3. Oral Disintegrating Tablets (ODTs) — dissolve rapidly without water πŸ’§

  4. Sublingual Tablets — for rapid absorption under the tongue πŸ‘…

  5. Spray formulations or drops — newer forms for fast onset πŸ’¨

🧩 Formulation depends on:

  • Desired onset and duration of action

  • Patient age and swallowing ability

  • Compliance and pharmacokinetic profile


6️⃣ How are Zolpidem Tartrate dosage forms prepared?

⚗️ General Preparation Process for Tablets (Example):

Step 1 – Blending:
Mix Zolpidem Tartrate API with excipients such as lactose monohydrate, microcrystalline cellulose, and crosscarmellose sodium to ensure uniform distribution. ⚙️

Step 2 – Granulation:
Perform wet granulation using a binder (e.g., povidone) or direct compression, depending on tablet type. πŸ§ͺ

Step 3 – Drying:
Dry the granules at low temperature (<60°C) to maintain stability and prevent degradation. 🌬️

Step 4 – Lubrication:
Add lubricants like magnesium stearate and colloidal silicon dioxide to improve flow and compression properties. ⚖️

Step 5 – Compression:
Compress into tablets using rotary tablet press machines to achieve uniform hardness and weight. πŸ’Š

Step 6 – Coating (optional):
Film-coat for controlled release, protection from moisture, or taste masking (especially in ODTs). 🎨

Step 7 – Packaging:
Pack in blister packs or HDPE bottles with desiccants to ensure stability and protect from moisture. πŸ“¦

7️⃣ What is the appropriate dosage form of Zolpidem Tartrate? πŸ’ŠπŸ“

The appropriate dosage form depends on patient needs, onset requirements, and convenience:

  • Immediate-Release (IR) Tablets:

    • Most common for short-term insomnia treatment πŸŒ™

    • Allows rapid sleep induction within 15–30 minutes

  • Extended-Release (ER) Tablets:

    • Suitable for patients with difficulty maintaining sleep

    • Designed for sustained plasma levels overnight ⏱️

  • Orally Disintegrating Tablets (ODTs):

    • Ideal for patients with swallowing difficulties

    • Dissolve rapidly on the tongue πŸ’§

  • Sublingual Tablets / Sprays:

    • Rapid absorption for immediate effect πŸ‘…⚡

πŸ’‘ Summary:
For most adults, immediate-release tablets are the preferred dosage form for Zolpidem, while ER or ODT forms are used based on patient-specific needs and ease of administration. ✅


8️⃣ When should Zolpidem Tartrate API (as medication) be taken? ⏰πŸŒ™

Although API itself isn’t consumed directly, formulations using Zolpidem Tartrate should follow:

  • Timing: Take immediately before bedtime (ensure 7–8 hours of sleep opportunity) πŸ›️

  • With or without food: Can be taken on an empty stomach for faster onset; food may delay absorption 🍽️

  • Adults: Typical dose 5–10 mg for immediate-release tablets, 6.25–12.5 mg for extended-release, depending on clinical response

  • Elderly/renally impaired: Lower doses recommended due to increased sensitivity ⚖️

⚠️ Precautions:

  • Avoid alcohol and other CNS depressants

  • Do not take if planning to wake up within 6–8 hours

  • Avoid activities requiring alertness the next morning (driving, operating machinery)


9️⃣ What are the effects and side effects of Zolpidem Tartrate? ⚡😴

Therapeutic Effects:

  • Sleep induction: Reduces time to fall asleep

  • Sleep maintenance: In extended-release forms, improves total sleep duration πŸŒ™

  • Minimal muscle relaxation and anxiolysis compared to benzodiazepines — reduces daytime sedation risk

Common Side Effects:

  • Drowsiness, fatigue 😴

  • Dizziness, headache

  • Gastrointestinal issues: nausea, diarrhea

  • Mild amnesia or forgetfulness

Serious or Rare Side Effects:

  • Complex sleep behaviors: sleepwalking, sleep-driving 🚨

  • Next-day sedation or impaired coordination

  • Allergic reactions or rash

  • Rare: hallucinations or mood changes

πŸ’‘ Management Tips:

  • Take lowest effective dose

  • Adequate sleep duration reduces next-day effects

  • Monitor elderly patients for falls or confusion


πŸ”Ÿ How is Zolpidem Tartrate API tested? πŸ§ͺ✅

Quality control ensures purity, potency, and safety before formulation:

  • Identity Tests:

    • IR spectroscopy, UV-Vis spectroscopy, HPLC retention time to confirm chemical structure

  • Assay / Potency:

    • HPLC determines API content (typically 98–102% of label claim)

  • Impurity Profile:

    • HPLC or LC-MS detects organic impurities and degradation products

    • Impurities controlled within ICH limits (<0.10% individually, <0.5% total)

  • Residual Solvent Testing:

    • Gas chromatography ensures solvents from synthesis are below safe limits

  • Physical Tests:

    • Melting point, loss on drying, water content

  • Microbiological Testing:

    • Total viable count, absence of pathogens (for sterility if needed)

πŸ“‹ Outcome:
Every batch is released with a Certificate of Analysis (CoA) detailing these results, ensuring regulatory compliance. ✅


1️⃣1️⃣ What tests are performed on Zolpidem Tartrate API? πŸ”πŸ§«

CategoryTestPurpose / Acceptance Criteria
IdentityIR, UV-Vis, HPLC retentionConfirm chemical structure
Assay / PotencyHPLC98–102% of label claim
Related SubstancesHPLC / LC-MSIndividual <0.1%, total <0.5%
Residual SolventsGCWithin ICH Q3C limits
Heavy MetalsICP-OES≤10 ppm
Loss on DryingGravimetric≤0.5%
Melting PointCapillary~193–196°C
Water ContentKarl Fischer≤0.5%
Microbial LimitsPlate count, absence of pathogensWithin pharmacopeial limits
PolymorphismXRPD / DSCConfirm correct crystalline form
Particle Size DistributionLaser diffractionEnsure uniformity for formulation

πŸ’‘ Summary:
Zolpidem Tartrate API manufactured by Swapnroop Drugs & Pharmaceuticals undergoes rigorous chemical, physical, and microbiological testing to guarantee purity, stability, and suitability for formulation into hypnotic medications. πŸŒ™πŸ’Š


1️⃣2️⃣ What are the challenges in manufacturing Zolpidem Tartrate API? ⚗️🏭

Producing high-quality Zolpidem Tartrate API involves several technical and regulatory challenges:

  1. Multi-step synthesis complexity πŸ”„

    • Requires condensation, cyclization, and amidation reactions.

    • Each step must be tightly controlled to prevent side reactions or impurity formation.

  2. Impurity control πŸ§ͺ

    • By-products from methylation, amidation, or cyclization can form.

    • Impurities must be kept within ICH guidelines (≤0.1% individually, ≤0.5% total).

  3. Polymorphism control πŸ’Ž

    • Zolpidem tartrate can crystallize in multiple forms.

    • Only a specific polymorph is pharmaceutically acceptable; controlling crystallization is critical.

  4. Moisture sensitivity πŸ’§

    • Slightly hygroscopic; moisture can affect flow, assay, and stability.

    • Requires controlled drying and low-humidity storage.

  5. Scale-up challenges ⚙️

    • Maintaining consistent yield, purity, and particle size from lab to industrial scale is demanding.

  6. Regulatory compliance πŸ›️

    • All raw materials, solvents, and intermediates must meet GMP standards.

    • Residual solvents, heavy metals, and microbial limits must be documented for international regulatory submission.


1️⃣3️⃣ What are the challenges in manufacturing Zolpidem dosage forms? πŸ’Š⚙️

Formulating zolpidem into tablets, ODTs, or ER forms presents additional hurdles:

  1. Poor water solubility πŸ’§

    • Zolpidem has moderate solubility; needs micronization, solid dispersions, or surfactants to enhance bioavailability.

  2. Content uniformity ⚖️

    • Fine particle size can lead to non-uniform mixing, especially in ODTs and ER tablets.

    • Requires precise blending and granulation.

  3. Stability during storage 🌑️

    • Sensitive to moisture and light, which can affect dissolution rate and potency.

    • Film coatings and moisture-proof packaging are essential.

  4. Excipients compatibility 🧩

    • Some binders or fillers may interact with API and alter dissolution or stability.

    • Extensive pre-formulation studies are needed.

  5. Controlled-release formulations ⏱️

    • ER tablets require careful polymer matrix selection and coating thickness control to maintain predictable drug release kinetics.


1️⃣4️⃣ What are the storage conditions for Zolpidem Tartrate API? πŸ“¦πŸŒ‘️

To maintain stability, potency, and purity:

  • Temperature: Store in a cool environment (<25°C) 🧊

  • Moisture: Protect from humidity (slightly hygroscopic) πŸ’§

  • Light: Keep away from direct sunlight ☀️

  • Containers: Use airtight, light-resistant HDPE drums or polyethylene-lined fiber drums πŸ›’️

  • Handling: Avoid prolonged exposure to air or strong oxidizing agents ⚗️

Proper storage ensures chemical integrity and consistent performance during formulation. ✅


1️⃣5️⃣ What is the packaging for Zolpidem Tartrate API? πŸ“¦πŸŽ€

Packaging specifications for commercial API supply:

  • Inner lining: Double-layer polyethylene bags to prevent moisture ingress 🧴

  • Outer container: HDPE drum or fiberboard drum (25 kg typical) πŸ›’️

  • Labeling: Batch number, manufacturing and expiry date, handling instructions, regulatory compliance marks 🏷️

  • Special considerations:

    • Desiccants may be included to control residual moisture

    • Light-protective liners for long-term storage

🌿 Swapnroop Drugs & Pharmaceuticals ensures:

  • GMP-compliant packaging

  • Protection during storage and transport

  • Regulatory-ready CoA and documentation


1️⃣6️⃣ What is the shelf life of Zolpidem Tartrate API? πŸ•’

The typical shelf life of Zolpidem Tartrate API is 3 to 5 years when stored under recommended conditions. Proper shelf life ensures that the API maintains potency, purity, and stability throughout its intended use.


Factors influencing shelf life:

  1. Temperature control 🌑️

    • Must be stored below 25°C in a cool environment.

  2. Moisture protection πŸ’§

    • Slightly hygroscopic; moisture can reduce stability or affect particle flow.

  3. Light exposure ☀️

    • Protected from direct sunlight to avoid degradation.

  4. Packaging quality πŸ“¦

    • HDPE/fiber drums with double polyethylene liners preserve integrity.

  5. Residual solvents & excipients ⚗️

    • Proper purification and drying ensure minimal degradation risk.


Stability confirmation πŸ”¬

  • Accelerated and long-term stability studies are performed following ICH Q1A(R2) guidelines.

  • Parameters monitored: assay, impurity profile, moisture content, polymorphic form, and color/appearance.

  • Ensures API remains within specification limits over the declared shelf life. ✅


πŸ’‘ Summary:
When stored under recommended conditions, Zolpidem Tartrate API from Swapnroop Drugs & Pharmaceuticals is stable, pure, and fully potent for 3–5 years, making it suitable for long-term formulation and distribution worldwide. πŸŒπŸ’Š




Comments

Popular posts from this blog

🌿 Probiotics IR Pellets – Fast-Acting Gut Health Solution by Swapnroop Drugs & Pharmaceuticals 🌿

🌱 Probiotics EC Pellets – Stabilized Gut Health Powerhouses by Swapnroop Drugs & Pharmaceuticals

Azithromycin Taste-Masked Powder: A Pediatric-Friendly Innovation by Swapnroop Drugs & Pharmaceuticals